搜尋
Unicycive Therapeutics Inc
UNCY添加自選
5.010USD
-0.290-5.47%
收盤 07-31 16:00（美東）報價延遲15分鐘
133.77M總市值
虧損本益比TTM
關於 Unicycive Therapeutics Inc 公司
Unicycive Therapeutics, Inc. is a biotechnology company developing treatments for kidney diseases. The Company's lead drug candidate, oxylanthanum carbonate (OLC), is an investigational phosphate binding agent being developed for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis. Its second asset, UNI-494, is a patent-protected new chemical entity in clinical development for the treatment of conditions related to acute kidney injury.
Unicycive Therapeutics Inc簡介
公司代碼UNCY
公司名稱Unicycive Therapeutics Inc
上市日期Jun 17, 2021
CEOGupta (Shalabh)
員工數量22
證券類型Ordinary Share
年結日Jun 17
公司地址4300 El Camino Real, Suite 210
城市LOS ALTOS
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編94022
電話16503840642
網址https://unicycive.com/
公司代碼UNCY
上市日期Jun 17, 2021
CEOGupta (Shalabh)
Unicycive Therapeutics Inc公司高管
名稱
名稱/職務
職務
持股
持股變動
Dr. Sandeep (Steve) Laumas, M.D.
Dr. Sandeep (Steve) Laumas, M.D.
Independent Director
Independent Director
10.58K
+0.01%
Dr. Pramod Gupta, Ph.D.
Dr. Pramod Gupta, Ph.D.
Executive Vice President - Pharmaceutical and Business Operations
Executive Vice President - Pharmaceutical and Business Operations
4.18K
--
Dr. Shalabh Gupta, M.D.
Dr. Shalabh Gupta, M.D.
Chairman of the Board, President, Chief Executive Officer, Founder
Chairman of the Board, President, Chief Executive Officer, Founder
--
--
Mr. John Townsend
Mr. John Townsend
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Saraswati (Sara) Kenkare-Mitra, Ph.D.
Dr. Saraswati (Sara) Kenkare-Mitra, Ph.D.
Independent Director
Independent Director
--
--
Dr. Gaurav Aggarwal, M.D.
Dr. Gaurav Aggarwal, M.D.
Independent Director
Independent Director
--
--
Mr. Doug Jermasek
Mr. Doug Jermasek
Executive Vice President - Corporate Strategy
Executive Vice President - Corporate Strategy
--
--
名稱
名稱/職務
職務
持股
持股變動
Dr. Sandeep (Steve) Laumas, M.D.
Dr. Sandeep (Steve) Laumas, M.D.
Independent Director
Independent Director
10.58K
+0.01%
Dr. Pramod Gupta, Ph.D.
Dr. Pramod Gupta, Ph.D.
Executive Vice President - Pharmaceutical and Business Operations
Executive Vice President - Pharmaceutical and Business Operations
4.18K
--
Dr. Shalabh Gupta, M.D.
Dr. Shalabh Gupta, M.D.
Chairman of the Board, President, Chief Executive Officer, Founder
Chairman of the Board, President, Chief Executive Officer, Founder
--
--
Mr. John Townsend
Mr. John Townsend
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Saraswati (Sara) Kenkare-Mitra, Ph.D.
Dr. Saraswati (Sara) Kenkare-Mitra, Ph.D.
Independent Director
Independent Director
--
--
Dr. Gaurav Aggarwal, M.D.
Dr. Gaurav Aggarwal, M.D.
Independent Director
Independent Director
--
--
常見問題
Unicycive Therapeutics Inc的前五大股東是誰？
Unicycive Therapeutics Inc的前五大股東如下：Dr. Sandeep (Steve) Laumas, M.D.
有多少機構持有Unicycive Therapeutics Inc(UNCY)的股份？
截至2026Q1，共有75家機構持有Unicycive Therapeutics Inc的股份，合計持有的股份價值約為9.56M，占公司總股份的35.81% 。與2025Q4相比，機構持股有所增加，增幅為450872.00。